Bajaj Electricals announced that to enable the expansion and diversification of the company's business operations for sustainable growth, the company has decided to enter into ‘Wires' as a new business line under its ‘Lighting Solutions' segment, in view of the growing demand in the wires industry.

The company is planning to launch the product shortly and assess the market to ascertain the investment required which will be determined based on various factors, including scale of business, operational requirements, and other prevailing external factors.

Aditya Birla Real Estate will hold a meeting of the Board of Directors of the Company on 28 January 2026.

Deepak Fertilizers & Petrochem. Corp. will hold a meeting of the Board of Directors of the Company on 29 January 2026.

Elgi Equipments will hold a meeting of the Board of Directors of the Company on 11 February 2026.

Setco Automotive will hold a meeting of the Board of Directors of the Company on 13 February 2026.

ABB India has successfully delivered a critical energy infrastructure modernization program by upgrading the automation and monitoring systems for Bharat Petroleum Corporation's (BPCL) Vadinar-Bina Pipeline (VBPL). This 935 km cross-country oil pipeline is vital for supporting India's energy security at a time of increasing energy demand, as it supplies 7.80 million metric tonnes per annum (MMTPA) to the Bina refinery.

The project scope included a complete ABB Ability™ SCADAvantage system modernization for the pipeline, the replacement of 35 Remote Terminal Units (RTU) across pumping, pigging and sectionalizing valve stations, the installation of new SCADA servers at Vadinar and Bina and strengthening security and cyber resilience through network protection, system hardening and centralized monitoring.

Tata Investment Corporation will hold a meeting of the Board of Directors of the Company on 30 January 2026.

NOCIL will hold a meeting of the Board of Directors of the Company on 11 February 2026.

Pfizer announced the following change in senior management:

• Nilesh Pendse is appointed as Category Lead – Vaccines of the Company with effect from 01 February 2026. Pendse shall accordingly be a Senior Management Personnel of the Company effective the said date.
• Manikantan Seshadrinathan – Category Lead, Hospitals & Rare Disease will transition to another role within the Pfizer Group Companies effective 01 February 2026, and shall accordingly cease to be a Senior Management Personnel of the Company effective 31 January 2026.
• Prashant Mahalingam, Category Lead – Internal Medicine, will take up additional responsibility of the Hospitals Business of the Company and shall be redesignated as Category Lead – Internal Medicine & Hospitals, effective 01 February 2026.

SRF announced that the Board of Directors of the Company at its meeting held on 20 January 2026, has recommended a Second Interim Dividend of Rs.5 per share (i.e.50%), subject to the approval of the shareholders.